Merus Labs International Inc. Co (MSLI) 1.53 $MSLI
Merus Labs Names Barry Fishman as Senior Advisor
Marketwire - Wed Apr 23, 6:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI), a Canadian publicly traded specialty pharmaceutical company, announced today that Barry Fishman has joined as Senior Advisor. In this part-time capacity, Barry will assist Merus Labs in identifying investment opportunities, facilitating key industry introductions, and advising the firm on strategic and operational issues. Barry has over 25 years of experience in the pharmaceutical industry and is the former President & CEO of Teva Canada. During his tenure, operating profit increased by 75% and market share grew by 70%. Barry is also the past Chair of the Canadian Generic Manufacturers Association. Barry started his pharmaceutical career at Eli Lilly, where he advanced through several cross-functional leadership roles, including Vice President of Marketing.
Merus Labs International Inc. Announces Closing on Full Exercise of Over-Allotment Option
Marketwire - Mon Mar 31, 7:48AM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the syndicate of investment dealers (the "Underwriters" has exercised in full the over-allotment option to purchase 1,764,750 common shares of the Company ("Shares" at a price of $1.70 per share granted to the Underwriters in connection with the Company's previously announced public offering which closed on March 25, 2014. The Company has today issued 1,764,750 Shares for additional gross proceeds of $3,000,075 upon closing of the exercise of the over-allotment option.
Merus Labs International Inc.: Completes $20 Million Bought Deal Financing
Marketwire - Tue Mar 25, 7:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters". Under the financing, Merus issued 11,765,000 common shares ("Shares" at a price of $1.70 per Share, for gross proceeds of $20,000,500.
IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Fri Mar 14, 6:55AM CDT
Trading resumes in:
Merus Labs International Inc. Announces $20 Million Bought Deal Financing
Marketwire - Thu Mar 13, 4:22PM CDT
Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("the Company" or "Merus" is pleased to announce that it has entered into an agreement with a syndicate of investment dealers (the "Underwriters" pursuant to which the Underwriters have agreed to purchase 11,765,000 common shares ("Shares" from the treasury of the Company, at a price of $1.70 per Share and offer them to the public by way of prospectus supplement (the "Offering".
IIROC Trading Halt - MSL (all issues)
CNW Group - Thu Mar 13, 3:55PM CDT
The following issues have been halted by IIROC:
Vansen Pharma Inc. appoints new President and CEO
CNW Group - Mon Mar 03, 7:30AM CST
Vansen Pharma Inc. [OTCQB: VNSN], a specialty pharmaceutical company, is pleased to announce the appointment of Dr. Ahmad Doroudian as its President and Chief Executive Officer. Dr. Doroudian was most recently the Chief Executive Officer and Vice Chairman of Merus Labs International Inc. (NASDAQ:MSLI - TSX:MSL), and brings with him a track record of accomplishment and success earned over his career in the healthcare industry.
Merus Labs International Inc. Announces First Quarter Results for Fiscal 2014
Marketwire - Fri Feb 14, 7:00AM CST
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for the first quarter of fiscal 2014.
Olympia Financial Group Inc. Named one of Alberta's Top 65 Employers
Marketwire Canada - Thu Feb 13, 12:01PM CST
Olympia Financial Group Inc. (TSX:OLY) is pleased to announce that it has been named one of Alberta's Top 65 Employers.
Cenkos Securities PLC Acquires Shares of EastCoal Inc.
Marketwire Canada - Thu Feb 13, 11:44AM CST
Cenkos Securities PLC of 6-8 Tokenhouse Yard, London, EC2R 7AS, United Kingdom ("Cenkos" announced today that on 6th February, 2014, Cenkos, the Nominated Adviser and broker in the United Kingdom to EastCoal Inc. (the "Issuer" and in respect of its common shares which are listed on both the TSX Venture Exchange and admitted to trading on AIM (the "Common Shares", acquired an aggregate of 3,996,435 Common Shares at a price of GBPGBP 0.001 per share and 350,000 Common Shares at a price of CAD$0.00183 per share and disposed of an aggregate of 120,000 Common Shares at a price of GBPGBP 0.0055 per share and 500,000 Common Shares at a price of CAD$0.00999 per share (the "Dealings".
Nasdaq stocks posting largest volume increases
AP - Tue Feb 04, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Merus Labs International Inc. Announces Results for Fiscal 2013
Marketwire - Mon Dec 30, 7:01AM CST
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its fiscal year 2013.
Merus Labs Names Barry Fishman as Senior Advisor
Marketwire - Wed Apr 23, 6:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI), a Canadian publicly traded specialty pharmaceutical company, announced today that Barry Fishman has joined as Senior Advisor. In this part-time capacity, Barry will assist Merus Labs in identifying investment opportunities, facilitating key industry introductions, and advising the firm on strategic and operational issues. Barry has over 25 years of experience in the pharmaceutical industry and is the former President & CEO of Teva Canada. During his tenure, operating profit increased by 75% and market share grew by 70%. Barry is also the past Chair of the Canadian Generic Manufacturers Association. Barry started his pharmaceutical career at Eli Lilly, where he advanced through several cross-functional leadership roles, including Vice President of Marketing. Merus Labs International Inc. Announces Closing on Full Exercise of Over-Allotment Option
Marketwire - Mon Mar 31, 7:48AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the syndicate of investment dealers (the "Underwriters" has exercised in full the over-allotment option to purchase 1,764,750 common shares of the Company ("Shares" at a price of $1.70 per share granted to the Underwriters in connection with the Company's previously announced public offering which closed on March 25, 2014. The Company has today issued 1,764,750 Shares for additional gross proceeds of $3,000,075 upon closing of the exercise of the over-allotment option. Merus Labs International Inc.: Completes $20 Million Bought Deal Financing
Marketwire - Tue Mar 25, 7:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters". Under the financing, Merus issued 11,765,000 common shares ("Shares" at a price of $1.70 per Share, for gross proceeds of $20,000,500. IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Fri Mar 14, 6:55AM CDT
Trading resumes in:
Merus Labs International Inc. Announces $20 Million Bought Deal Financing
Marketwire - Thu Mar 13, 4:22PM CDT
Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("the Company" or "Merus"
is pleased to announce that it has entered into an agreement with a syndicate of investment dealers (the "Underwriters" pursuant to which the Underwriters have agreed to purchase 11,765,000 common shares ("Shares" from the treasury of the Company, at a price of $1.70 per Share and offer them to the public by way of prospectus supplement (the "Offering". IIROC Trading Halt - MSL (all issues)
CNW Group - Thu Mar 13, 3:55PM CDT
The following issues have been halted by IIROC:
Vansen Pharma Inc. appoints new President and CEO
CNW Group - Mon Mar 03, 7:30AM CST
Vansen Pharma Inc. [OTCQB: VNSN], a specialty pharmaceutical company, is pleased to announce the appointment of Dr. Ahmad Doroudian as its President and Chief Executive Officer. Dr. Doroudian was most recently the Chief Executive Officer and Vice Chairman of Merus Labs International Inc. (NASDAQ:MSLI - TSX:MSL), and brings with him a track record of accomplishment and success earned over his career in the healthcare industry.
Merus Labs International Inc. Announces First Quarter Results for Fiscal 2014
Marketwire - Fri Feb 14, 7:00AM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for the first quarter of fiscal 2014. Olympia Financial Group Inc. Named one of Alberta's Top 65 Employers
Marketwire Canada - Thu Feb 13, 12:01PM CST
Olympia Financial Group Inc. (TSX:OLY) is pleased to announce that it has been named one of Alberta's Top 65 Employers.
Cenkos Securities PLC Acquires Shares of EastCoal Inc.
Marketwire Canada - Thu Feb 13, 11:44AM CST
Cenkos Securities PLC of 6-8 Tokenhouse Yard, London, EC2R 7AS, United Kingdom ("Cenkos"
announced today that on 6th February, 2014, Cenkos, the Nominated Adviser and broker in the United Kingdom to EastCoal Inc. (the "Issuer" and in respect of its common shares which are listed on both the TSX Venture Exchange and admitted to trading on AIM (the "Common Shares", acquired an aggregate of 3,996,435 Common Shares at a price of GBPGBP 0.001 per share and 350,000 Common Shares at a price of CAD$0.00183 per share and disposed of an aggregate of 120,000 Common Shares at a price of GBPGBP 0.0055 per share and 500,000 Common Shares at a price of CAD$0.00999 per share (the "Dealings". Nasdaq stocks posting largest volume increases
AP - Tue Feb 04, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Merus Labs International Inc. Announces Results for Fiscal 2013
Marketwire - Mon Dec 30, 7:01AM CST
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for its fiscal year 2013. 
